The Top 10 Reasons for Choosing Open Source Data Integration

whitePaper | August 20, 2021

While finding and creating insights can often feel like luck, there are proven methodologies you can use to ensure you’re seeing regular insight from your on-hand data. Access this short e-book to learn how you can start seeing regular, valuable insight success from you big data and analytics investments.

whitePaper | January 11, 2023

The world of master data management (MDM) is a complicated place to navigate and its native speakers use a language sometimes only they themselves understand. It is packed with complex descriptions, esoteric lingo and acronyms.

whitePaper | May 6, 2022

Every organization today recognizes the strategic value of generating actionable insights from their enterprise data.

whitePaper | May 15, 2023

Genomics is the study of the complete set of DNA in a person or other organism. DNA underpins a large proportion of an individual's health and disease status, therefore a genomic medicine approach is increasingly being applied in clinical settings. Genomic medicine is where the study of clinical outcomes (measurable changes in health and well-being) is combined with genomics so researchers can better understand how a person’s genome contributes to disease. Increasingly, advances in our understanding of the genome are contributing to improvements in disease diagnosis, drug discovery and targeted therapeutics.

whitePaper | February 19, 2020

Artificial Intelligence is developing fast. It will change our lives by improving healthcare (e.g. making diagnosis more precise, enabling better prevention of diseases), increasing the efficiency of farming, contributing to climate change mitigation and adaptation, improving the efficiency of production systems through predictive maintenance, increasing the security of Europeans, and in many other ways that we can only begin to imagine. At the same time, Artificial Intelligence (AI) entails a number of potential risks, such as opaque decision-making, gender-based or other kinds of discrimination, intrusion in our private lives or being used for criminal purposes.

whitePaper | July 6, 2023

Cross border data flows came to prominence under Japan’s G20 Presidency in 2019, with the Data Free Flow with Trust (DFFT) framework. Since then, the G20 Presidencies have set DFFT as a major priority in the promotion of worldwide digitisation, building the pillars that led G7 leaders to endorse and commit to a roadmap for cooperation on DFFT. Cross-border e-commerce has had a 45-fold increase1 in a decade, reaching an estimated USD2.7 trillion by 2023.2 Nearly two-thirds of global commerce is related to digital technology, with companies and governments investing an estimated USD6.8 trillion in digital transformation initiatives between 2020 and 2023.3